InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Brudnick Richard. Director active across 2 companies, notably Scholar Rock Holding Corp. Aggregated, 5 reports have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €143k. Activity tracked since 27 June 2024. The latest transaction was filed on 4 June 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Brudnick Richard is a declarant linked to Scholar Rock Holding Corp, where he is Director, and to Prime Medicine, Inc., where he is Chief Business Officer. Across 5 filings in total, the 5 sampled filings run from 2024-07-01 to 2026-06-08, with buys of EUR 21076 and sells of EUR 121745, and the most common transaction nature is Attribution.